Patent - Abbreviated New Drug Application Cases filed in Delaware
Cases 1 - 10 of 372
Exeltis USA, Inc. et al v. Lupin Ltd. et al
as 1:2024cv00732
Plaintiff: Exeltis USA, Inc., Laboratorios Leon Farma, S.A., Chemo Iberica, S.A. and others
Defendant: Lupin Ltd. and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Merck KGaA et al v. TWi Pharmaceuticals, Inc. et al
as 1:2024cv00700
Plaintiff: Merck KGaA, Merck Serono SA and Ares Trading SA
Defendant: TWi Pharmaceuticals, Inc. and TWi Pharmaceuticals USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Amicus Therapeutics US, LLC et al v. Teva Pharmaceuticals USA, Inc. et al
as 1:2024cv00696
Plaintiff: Amicus Therapeutics US, LLC and Amicus Therapeutics, Inc.
Defendant: Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Amicus Therapeutics US, LLC et al v. Aurobindo Pharma Ltd. et al
as 1:2024cv00698
Plaintiff: Amicus Therapeutics US, LLC and Amicus Therapeutics, Inc.
Defendant: Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ViiV Healthcare Company et al v. Hetero USA, Inc. et al
as 1:2024cv00657
Plaintiff: ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited and Shionogi & Co., Ltd.
Defendant: Hetero USA, Inc., Hetero Labs Limited Unit-V and Hetero Labs Limited
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
Acerta Pharma B.V. et al v. Cipla Limited et al
as 1:2024cv00587
Plaintiff: Acerta Pharma B.V., AstraZeneca UK Limited, AstraZeneca Pharmaceuticals LP and others
Defendant: Cipla Limited and Cipla USA, Inc.
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
Exelixis, Inc. v. Cipla Ltd. et al
as 1:2024cv00565
Plaintiff: Exelixis, Inc.
Defendant: Cipla Ltd. and Cipla USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ViiV Healthcare Company et al v. Hetero USA, Inc. et al
as 1:2024cv00547
Plaintiff: ViiV Healthcare Company, Shionogi & Co., Ltd. and ViiV Healthcare UK (No. 3) Limited
Defendant: Hetero USA, Inc., Hetero Labs Limited Unit-III and Hetero Labs Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Horizon Therapeutics U.S. Holding LLC et al v. Teva Pharmaceuticals, Inc.
as 1:2024cv00432
Plaintiff: Horizon Therapeutics U.S. Holding LLC and Horizon Therapeutics USA, Inc.
Defendant: Teva Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation et al v. Teva Pharmaceuticals Inc. et al
as 1:2024cv00428
Plaintiff: Novartis Pharmaceuticals Corporation and Novartis AG
Defendant: Teva Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?